Toward Single-Time-Point Image-Based Dosimetry of


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
05 2023
Historique:
received: 29 06 2022
revised: 14 11 2022
medline: 1 5 2023
pubmed: 20 1 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

Radiopharmaceutical therapies (RPTs) with

Identifiants

pubmed: 36657980
pii: jnumed.122.264594
doi: 10.2967/jnumed.122.264594
pmc: PMC10152120
doi:

Substances chimiques

PSMA-617 0
Dipeptides 0
Prostate-Specific Antigen EC 3.4.21.77
Heterocyclic Compounds, 1-Ring 0
Radiopharmaceuticals 0
Lutetium 5H0DOZ21UJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-774

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Mol Imaging Biol. 2016 Jun;18(3):437-45
pubmed: 26920354
J Nucl Med. 2016 Jul;57(7):1006-13
pubmed: 26795286
Clin Cancer Res. 2021 Jul 1;27(13):3595-3601
pubmed: 33883176
J Nucl Med. 2018 Jan;59(1):75-81
pubmed: 28588150
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1976-88
pubmed: 24915892
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):460-469
pubmed: 34218300
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51
pubmed: 26318602
Cancers (Basel). 2021 Aug 01;13(15):
pubmed: 34359784
J Nucl Med. 2019 Sep;60(9):1277-1283
pubmed: 30850484
J Nucl Med. 2022 Aug;63(8):1199-1207
pubmed: 34887335
J Nucl Med. 2020 Jul;61(7):1030-1036
pubmed: 31806772
J Nucl Med. 2021 Jul 1;62(7):1006-1011
pubmed: 33127625
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29
pubmed: 33166497
EJNMMI Phys. 2021 Mar 12;8(1):26
pubmed: 33709253
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Phys Med Biol. 2019 Aug 28;64(17):175006
pubmed: 31287093
EJNMMI Phys. 2018 Oct 15;5(1):25
pubmed: 30318563
J Nucl Med. 2019 Apr;60(4):517-523
pubmed: 30291192
Med Phys. 2018 May;45(5):2318-2324
pubmed: 29577338
EJNMMI Phys. 2018 Dec 20;5(1):33
pubmed: 30569328
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
PET Clin. 2021 Oct;16(4):627-641
pubmed: 34537133
EJNMMI Phys. 2017 Dec;4(1):2
pubmed: 28063068
J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S
pubmed: 34857622
J Nucl Med. 2016 Jan;57(1):151-62
pubmed: 26471692
EJNMMI Res. 2015 Dec;5(1):114
pubmed: 26099227
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544
pubmed: 31440799
EJNMMI Res. 2018 Aug 3;8(1):76
pubmed: 30076556
EJNMMI Phys. 2020 Jun 17;7(1):41
pubmed: 32556844
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Phys Med Biol. 2022 Jan 19;67(2):
pubmed: 34965519

Auteurs

Julia Brosch-Lenz (J)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; jbrosch@bccrc.ca.
Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.

Astrid Delker (A)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Friederike Völter (F)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Lena M Unterrainer (LM)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Lena Kaiser (L)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Sibylle Ziegler (S)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Arman Rahmim (A)

Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Physics, University of British Columbia, Vancouver, British Columbia, Canada; and.

Carlos Uribe (C)

Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Functional Imaging, BC Cancer, Vancouver, British Columbia, Canada.

Guido Böning (G)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH